198 related articles for article (PubMed ID: 27094504)
41. In vitro growth inhibition of human cancer cells by novel honokiol analogs.
Lin JM; Prakasha Gowda AS; Sharma AK; Amin S
Bioorg Med Chem; 2012 May; 20(10):3202-11. PubMed ID: 22533983
[TBL] [Abstract][Full Text] [Related]
42. A peroxisome proliferator-activated receptor gamma antagonist induces vimentin cleavage and inhibits invasion in high-grade hepatocellular carcinoma.
Kim KR; Choi HN; Lee HJ; Baek HA; Park HS; Jang KY; Chung MJ; Moon WS
Oncol Rep; 2007 Oct; 18(4):825-32. PubMed ID: 17786342
[TBL] [Abstract][Full Text] [Related]
43. Improved effects of honokiol on temozolomide-induced autophagy and apoptosis of drug-sensitive and -tolerant glioma cells.
Chio CC; Chen KY; Chang CK; Chuang JY; Liu CC; Liu SH; Chen RM
BMC Cancer; 2018 Apr; 18(1):379. PubMed ID: 29614990
[TBL] [Abstract][Full Text] [Related]
44. Pioglitazone induces cell growth arrest and activates mitochondrial apoptosis in human uterine leiomyosarcoma cells by a peroxisome proliferator-activated receptor γ-independent mechanism.
Lützen U; Zhao Y; Lucht K; Zuhayra M; Marx M; Cascorbi I; Culman J
Naunyn Schmiedebergs Arch Pharmacol; 2017 Jan; 390(1):37-48. PubMed ID: 27664035
[TBL] [Abstract][Full Text] [Related]
45. The PPARgamma ligands PGJ2 and rosiglitazone show a differential ability to inhibit proliferation and to induce apoptosis and differentiation of human glioblastoma cell lines.
Morosetti R; Servidei T; Mirabella M; Rutella S; Mangiola A; Maira G; Mastrangelo R; Koeffler HP
Int J Oncol; 2004 Aug; 25(2):493-502. PubMed ID: 15254749
[TBL] [Abstract][Full Text] [Related]
46. Magnolol enhances adipocyte differentiation and glucose uptake in 3T3-L1 cells.
Choi SS; Cha BY; Lee YS; Yonezawa T; Teruya T; Nagai K; Woo JT
Life Sci; 2009 Jun; 84(25-26):908-14. PubMed ID: 19376135
[TBL] [Abstract][Full Text] [Related]
47. Pro-apoptotic and anticancer properties of Thapring - A Tibetan herbal formulation.
Choedon T; Dolma D; Kumar V
J Ethnopharmacol; 2011 Sep; 137(1):320-6. PubMed ID: 21658439
[TBL] [Abstract][Full Text] [Related]
48. Honokiol Is a Potential Therapeutic Agent and Has a Synergistic Effect With 5-FU in Human Urothelial Cell Carcinoma Cells.
Lee MY; Shi CS; Hsu YC; Huang KJ; Chen SH; Zhao PW; Chung HC; Huang YC; Lee YR
Anticancer Res; 2019 Dec; 39(12):6555-6565. PubMed ID: 31810921
[TBL] [Abstract][Full Text] [Related]
49. Honokiol induces autophagy and apoptosis of osteosarcoma through PI3K/Akt/mTOR signaling pathway.
Li Z; Dong H; Li M; Wu Y; Liu Y; Zhao Y; Chen X; Ma M
Mol Med Rep; 2018 Feb; 17(2):2719-2723. PubMed ID: 29207060
[TBL] [Abstract][Full Text] [Related]
50. Inhibitory role of peroxisome proliferator-activated receptor gamma in hepatocarcinogenesis in mice and in vitro.
Yu J; Shen B; Chu ES; Teoh N; Cheung KF; Wu CW; Wang S; Lam CN; Feng H; Zhao J; Cheng AS; To KF; Chan HL; Sung JJ
Hepatology; 2010 Jun; 51(6):2008-19. PubMed ID: 20512989
[TBL] [Abstract][Full Text] [Related]
51. Hyperforin Inhibits Cell Growth by Inducing Intrinsic and Extrinsic Apoptotic Pathways in Hepatocellular Carcinoma Cells.
Chiang IT; Chen WT; Tseng CW; Chen YC; Kuo YC; Chen BJ; Weng MC; Lin HJ; Wang WS
Anticancer Res; 2017 Jan; 37(1):161-167. PubMed ID: 28011486
[TBL] [Abstract][Full Text] [Related]
52. Upregulation of PTEN involved in rosiglitazone-induced apoptosis in human hepatocellular carcinoma cells.
Cao LQ; Chen XL; Wang Q; Huang XH; Zhen MC; Zhang LJ; Li W; Bi J
Acta Pharmacol Sin; 2007 Jun; 28(6):879-87. PubMed ID: 17506947
[TBL] [Abstract][Full Text] [Related]
53. Rosiglitazone enhances fluorouracil-induced apoptosis of HT-29 cells by activating peroxisome proliferator-activated receptor gamma.
Zhang YQ; Tang XQ; Sun L; Dong L; Qin Y; Liu HQ; Xia H; Cao JG
World J Gastroenterol; 2007 Mar; 13(10):1534-40. PubMed ID: 17461445
[TBL] [Abstract][Full Text] [Related]
54. Antineoplastic Effects of Honokiol on Melanoma.
Guillermo-Lagae R; Santha S; Thomas M; Zoelle E; Stevens J; Kaushik RS; Dwivedi C
Biomed Res Int; 2017; 2017():5496398. PubMed ID: 28194418
[TBL] [Abstract][Full Text] [Related]
55. Mistletoe lectin-I augments antiproliferative effects of the PPARgamma agonist rosiglitazone on human malignant melanoma cells.
Freudlsperger C; Dahl A; Hoffmann J; Reinert S; Schumacher U
Phytother Res; 2010 Sep; 24(9):1354-8. PubMed ID: 20812278
[TBL] [Abstract][Full Text] [Related]
56. Anti-tumor effect of honokiol alone and in combination with other anti-cancer agents in breast cancer.
Liu H; Zang C; Emde A; Planas-Silva MD; Rosche M; Kühnl A; Schulz CO; Elstner E; Possinger K; Eucker J
Eur J Pharmacol; 2008 Sep; 591(1-3):43-51. PubMed ID: 18588872
[TBL] [Abstract][Full Text] [Related]
57. Induction of G1 phase arrest and apoptosis in MDA-MB-231 breast cancer cells by troglitazone, a synthetic peroxisome proliferator-activated receptor gamma (PPARgamma) ligand.
Yu HN; Lee YR; Noh EM; Lee KS; Kim JS; Song EK; Han MK; Lee YC; Kwon KB; Lee SJ; Youn HJ; Jung SH
Cell Biol Int; 2008 Aug; 32(8):906-12. PubMed ID: 18474441
[TBL] [Abstract][Full Text] [Related]
58. Honokiol induces cytotoxic and cytostatic effects in malignant melanoma cancer cells.
Kaushik G; Ramalingam S; Subramaniam D; Rangarajan P; Protti P; Rammamoorthy P; Anant S; Mammen JM
Am J Surg; 2012 Dec; 204(6):868-73. PubMed ID: 23231930
[TBL] [Abstract][Full Text] [Related]
59. Growth inhibition of human hepatoma cells by acyclic retinoid is associated with induction of p21(CIP1) and inhibition of expression of cyclin D1.
Suzui M; Masuda M; Lim JT; Albanese C; Pestell RG; Weinstein IB
Cancer Res; 2002 Jul; 62(14):3997-4006. PubMed ID: 12124333
[TBL] [Abstract][Full Text] [Related]
60. Combination of peroxisome proliferator-activated receptor gamma and retinoid X receptor agonists induces sodium/iodide symporter expression and inhibits cell growth of human thyroid cancer cells.
Chen JY; Wang JJ; Lee HC; Chi CW; Lee CH; Hsu YC
J Chin Med Assoc; 2020 Oct; 83(10):923-930. PubMed ID: 33009242
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]